{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:53:48Z","timestamp":1780379628655,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T00:00:00Z","timestamp":1370908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/nrneph.2013.108","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T12:18:30Z","timestamp":1370953110000},"page":"478-483","source":"Crossref","is-referenced-by-count":31,"title":["Biomarkers for incident CKD: a new framework for interpreting the literature"],"prefix":"10.1038","volume":"9","author":[{"given":"Michael G.","family":"Shlipak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica C.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,11]]},"reference":[{"key":"BFnrneph2013108_CR1","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","volume":"113","author":"RS Vasan","year":"2006","unstructured":"Vasan, R. S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113, 2335\u20132362 (2006).","journal-title":"Circulation"},{"key":"BFnrneph2013108_CR2","doi-asserted-by":"crossref","unstructured":"Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89\u201395 (2001).","DOI":"10.1067\/mcp.2001.113989"},{"key":"BFnrneph2013108_CR3","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am. J. Kidney Dis. 39, S1\u2013S246 (2002)."},{"key":"BFnrneph2013108_CR4","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh, J.  et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038\u20132047 (2007).","journal-title":"JAMA"},{"key":"BFnrneph2013108_CR5","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/jnci\/djn326","volume":"100","author":"MS Pepe","year":"2008","unstructured":"Pepe, M. S., Feng, Z., Janes, H., Bossuyt, P. M. & Potter, J. D. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J. Natl Cancer Inst. 100, 1432\u20131438 (2008).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrneph2013108_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina, M. J., D'Agostino, R. B. Sr & Steyerberg, E. W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med. 30, 11\u201321 (2011).","journal-title":"Stat. Med."},{"key":"BFnrneph2013108_CR7","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1515\/CCLM.2010.340","volume":"48","author":"MJ Pencina","year":"2010","unstructured":"Pencina, M. J., D'Agostino, R. B. & Vasan, R. S. Statistical methods for assessment of added usefulness of new biomarkers. Clin. Chem. Lab. Med. 48, 1703\u20131711 (2010).","journal-title":"Clin. Chem. Lab. Med."},{"key":"BFnrneph2013108_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/aje\/kws207","volume":"176","author":"MJ Pencina","year":"2012","unstructured":"Pencina, M. J., D'Agostino, R. B., Pencina, K. M., Janssens, A. C. & Greenland, P. Interpreting incremental value of markers added to risk prediction models. Am. J. Epidemiol. 176, 473\u2013481 (2012).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrneph2013108_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/sim.3106","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina, M. J., D'Agostino, R. B. Sr, D'Agostino, R. B. Jr & Vasan, R. S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond (discussion). Stat. Med. 27, 207\u2013212 (2008).","journal-title":"Stat. Med."},{"key":"BFnrneph2013108_CR10","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/aje\/kwr013","volume":"173","author":"MS Pepe","year":"2011","unstructured":"Pepe, M. S. Problems with risk reclassification methods for evaluating prediction models. Am. J. Epidemiol. 173, 1327\u20131335 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrneph2013108_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.7326\/0003-4819-149-10-200811180-00009","volume":"149","author":"H Janes","year":"2008","unstructured":"Janes, H., Pepe, M. S. & Gu, W. Assessing the value of risk predictions by using risk stratification tables. Ann. Intern. Med. 149, 751\u2013760 (2008).","journal-title":"Ann. Intern. Med."},{"key":"BFnrneph2013108_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng.568","volume":"42","author":"A Kottgen","year":"2009","unstructured":"Kottgen, A.  et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat. Genet. 42, 376\u2013384 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrneph2013108_CR13","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1681\/ASN.2011040434","volume":"22","author":"N Papeta","year":"2011","unstructured":"Papeta, N.  et al. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J. Am. Soc. Nephrol. 22, 1991\u20131996 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013108_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","volume":"22","author":"JB Kopp","year":"2011","unstructured":"Kopp, J. B.  et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 22, 2129\u20132137 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013108_CR15","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1681\/ASN.2011050519","volume":"22","author":"DJ Friedman","year":"2011","unstructured":"Friedman, D. J., Kozlitina, J., Genovese, G., Jog, P. & Pollak, M. R. Population-based risk assessment of APOL1 on renal disease. J. Am. Soc. Nephrol. 22, 2098\u20132105 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013108_CR16","doi-asserted-by":"crossref","unstructured":"Xu, R. & Zuo, L. Low birthweight and chronic kidney disease. Nephrology (Carlton) 15 (Suppl. 2), 18\u201322.","DOI":"10.1111\/j.1440-1797.2010.01306.x"},{"key":"BFnrneph2013108_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.ki.5002747","volume":"73","author":"S Li","year":"2008","unstructured":"Li, S.  et al. Low birth weight is associated with chronic kidney disease only in men. Kidney Int. 73, 637\u2013642 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2013108_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.ackd.2010.03.011","volume":"17","author":"P Soderland","year":"2010","unstructured":"Soderland, P., Lovekar, S., Weiner, D. E., Brooks, D. R. & Kaufman, J. S. Chronic kidney disease associated with environmental toxins and exposures. Adv. Chronic Kidney Dis. 17, 254\u2013264 (2010).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"BFnrneph2013108_CR19","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJM200305013481815","volume":"348","author":"CG Elinder","year":"2003","unstructured":"Elinder, C. G. & Alvestrand, A. Environmental lead exposure and chronic renal disease (author reply). N. Engl. J. Med. 348, 1810\u20131812 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2013108_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.atherosclerosis.2008.08.016","volume":"204","author":"MG Shlipak","year":"2008","unstructured":"Shlipak, M. G.  et al. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis 204, 298\u2013303 (2008).","journal-title":"Atherosclerosis"},{"key":"BFnrneph2013108_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1053\/j.ajkd.2012.02.335","volume":"60","author":"JS Hiramoto","year":"2012","unstructured":"Hiramoto, J. S.  et al. Inflammation and Coagulation Markers and Kidney Function Decline: The Multi-Ethnic Study of Atherosclerosis. Am. J. Kidney Dis. 60, 225\u2013232 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2013108_CR22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nbt.1624","volume":"28","author":"Y Yu","year":"2010","unstructured":"Yu, Y.  et al. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nat. Biotechnol. 28, 470\u2013477 (2010).","journal-title":"Nat. Biotechnol."},{"key":"BFnrneph2013108_CR23","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/ki.1994.122","volume":"45","author":"T Yamamoto","year":"1994","unstructured":"Yamamoto, T. & Noble, N. A. Sustained expression of TGF-\u03b21 underlies development of progressive kidney fibrosis. Kidney Int. 45, 916\u2013927 (1994).","journal-title":"Kidney Int."},{"key":"BFnrneph2013108_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ki.1996.105","volume":"49","author":"T Wada","year":"1996","unstructured":"Wada, T.  et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int. 49, 761\u2013767 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph2013108_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1053\/j.ajkd.2012.05.014","volume":"60","author":"CA Peralta","year":"2012","unstructured":"Peralta, C. A.  et al. The associations of urinary levels of kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the multi-ethnic study of atherosclerosis (MESA). Am. J. Kidney Dis. 60, 904\u2013911 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2013108_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000330699","volume":"34","author":"BC Astor","year":"2011","unstructured":"Astor, B. C.  et al. Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study. Am. J. Nephrol. 34, 291\u2013297 (2011).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2013108_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1523-1755.2004.00845.x","volume":"66","author":"AJ Bleyer","year":"2004","unstructured":"Bleyer, A. J., Hart, T. C., Shihabi, Z., Robins, V. & Hoyer, J. R. Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein. Kidney Int. 66, 974\u2013977 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph2013108_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1681\/ASN.2009070725","volume":"21","author":"A Kottgen","year":"2010","unstructured":"Kottgen, A.  et al. Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J. Am. Soc. Nephrol. 21, 337\u2013344 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2013108_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2369-12-2","volume":"12","author":"MG Shlipak","year":"2011","unstructured":"Shlipak, M. G.  et al. Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease. BMC Nephrol. 12, 2 (2011).","journal-title":"BMC Nephrol."},{"key":"BFnrneph2013108_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/0971-4065.91179","volume":"22","author":"S Torabinejad","year":"2012","unstructured":"Torabinejad, S.  et al. Urinary monocyte chemotactic protein-1 and transforming growth factor-\u03b2 in systemic lupus erythematosus. Indian J. Nephrol. 22, 5\u201312 (2012).","journal-title":"Indian J. Nephrol."},{"key":"BFnrneph2013108_CR31","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1053\/j.ajkd.2010.11.022","volume":"57","author":"CM O'Seaghdha","year":"2011","unstructured":"O'Seaghdha, C. M.  et al. Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population. Am. J. Kidney Dis. 57, 841\u2013849 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2013108_CR32","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/j.ajkd.2010.11.021","volume":"57","author":"S Shastri","year":"2011","unstructured":"Shastri, S.  et al. Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). Am. J. Kidney Dis. 57, 832\u2013840 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2013108_CR33","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1681\/ASN.2010010085","volume":"21","author":"CS Fox","year":"2010","unstructured":"Fox, C. S.  et al. A multi-marker approach to predict incident CKD and microalbuminuria. J. Am. Soc. Nephrol. 21, 2143\u20132149 (2010).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.108","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:40:29Z","timestamp":1684471229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2013.108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,11]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFnrneph2013108"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2013.108","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,11]]}}}